Why the study?
Does interleukin-1 inhibition by anakinra improve vascular and left ventricular function in patients with rheumatoid arthritis?
Does interleukin-1 inhibition by anakinra improve vascular and left ventricular function in patients with rheumatoid arthritis?
Anakinra improves vascular and left ventricular function and reduces nitrooxidative stress in patients with rheumatoid arthritis.
Anakinra improves vascular and LV function in RA; confirms IL-1 inhibition as a modifiable target for cardiovascular complications.
Interleukin-1 inhibition improves vascular and left ventricular function and is associated with reduction of nitrooxidative stress and endothelin.
No takes yet. Share an insight, caveat, or question.
Ikonomidis et al. (2008) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: